Appeal in US embryonic stem cell case provokes little worry
This article was originally published in Scrip
Executive Summary
The Obama administration was back in federal court on 23 April again defending federal funding for human embryonic stem cell (hESC) research and the rules put in place in 2009 by the US National Institutes of Health (NIH) governing how taxpayer dollars are allocated and used for those activities.